[Use of clomipramine in psychiatry. Considerations on 4 years' experimentation].
D000275:Adjustment Disorders / Q000188:drug therapy*; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy; D001714:Bipolar Disorder / Q000188:drug therapy*; D003863:Depression / Q000188:drug therapy*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D003984:Dibenzazepines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011437:Propylamines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011581:Psychological Tests; D013997:Time Factors
D000928:Antidepressive Agents; D003984:Dibenzazepines; D011437:Propylamines
Utilisation de la clomipramine en psychiatrie. Réflexions sur quatre années d'expérience.